THERAVANCE, INC. COMMON STOCK PURCHASE AGREEMENT [date]Common Stock Purchase Agreement • May 4th, 2011 • Theravance Inc • Pharmaceutical preparations • Delaware
THIS COMMON STOCK PURCHASE AGREEMENT (the “Agreement”) is made as of the day of , by and among Theravance, Inc., a Delaware corporation (the “Company”), Glaxo Group Limited, a limited liability company organized under the laws of England and Wales (the “Investor”), and solely for the purposes of Sections 6.1, 6.2, 6.3, 6.4, 6.5, 6.6, 6.7, 6.9, 6.10, 6.11, 6.12, 6.13, 6.14, 6.17 and 6.18 hereof, GlaxoSmithKline LLC, a Delaware limited liability company, the successor entity to SmithKline Beecham Corporation, a Pennsylvania corporation (“GSK”).
THERAVANCE, INC. 2004 EQUITY INCENTIVE PLAN: PERFORMANCE CASH AWARD AGREEMENTPerformance Cash Award Agreement • May 4th, 2011 • Theravance Inc • Pharmaceutical preparations
You have been granted a Performance Cash Award by Theravance, Inc. (the “Company”) on the terms set forth in this Performance Cash Award Agreement (the “Agreement”):
